He discusses his session on endocrine pathways and therapeutic options for patients with nonalcoholic fatty liver disease, which he presented at Harvard University’s 21st Annual Symposium on NAFLD.
He discusses his session on endocrine pathways and therapeutic options for patients with nonalcoholic fatty liver disease, which he presented at Harvard University’s 21st Annual Symposium on NAFLD.
He discusses his session on endocrine pathways and therapeutic options for patients with nonalcoholic fatty liver disease, which he presented at Harvard University’s 21st Annual Symposium on NAFLD.
In this podcast, Louis Caplan, MD, from Beth Israel Deaconess Medical Center talks about detecting penetrating artery disease, prevention of events, and the antiplatelet agents used to treat such events.
...
In this podcast, Louis Caplan, MD, from Beth Israel Deaconess Medical Center talks about detecting penetrating artery disease, prevention of events, and the antiplatelet agents used to treat such events.
...
In this podcast, Louis Caplan, MD, from Beth Israel Deaconess Medical Center talks about detecting penetrating artery disease, prevention of events, and the antiplatelet agents used to treat such events.
...
In this podcast, Meredith McCormack, MD, highlights the key findings of the American Lung Association's 21st annual State of the Air report and suggests how the information can help guide your conversations...
In this podcast, Meredith McCormack, MD, highlights the key findings of the American Lung Association's 21st annual State of the Air report and suggests how the information can help guide your conversations...
In this podcast, Meredith McCormack, MD, highlights the key findings of the American Lung Association's 21st annual State of the Air report and suggests how the information can help guide your conversations...
She discusses her research on assays for measuring drug concentrations and anti-drug antibodies, as well as algorithmic approaches to proactive therapeutic drug monitoring and how they help patients with...
